Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Merck
US Army
QuintilesIMS
Federal Trade Commission
Express Scripts
Deloitte
Accenture
McKinsey

Generated: August 18, 2017

DrugPatentWatch Database Preview

OSMITROL 15% IN WATER Drug Profile

« Back to Dashboard

Which patents cover Osmitrol 15% In Water, and what generic Osmitrol 15% In Water alternatives are available?

Osmitrol 15% In Water is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in OSMITROL 15% IN WATER is mannitol. There are seventeen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mannitol profile page.

Summary for Tradename: OSMITROL 15% IN WATER

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list165
Clinical Trials: see list1,746
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OSMITROL 15% IN WATER at DailyMed

Pharmacology for Tradename: OSMITROL 15% IN WATER

Drug ClassOsmotic Diuretic
Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Diuresis
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
OSMITROL 15% IN WATER
mannitol
INJECTABLE;INJECTION013684-004Approved Prior to Jan 1, 1982APRXNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
mannitol
INJECTABLE;INJECTION013684-008Approved Prior to Jan 1, 1982APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
US Army
Cantor Fitzgerald
Julphar
Federal Trade Commission
Queensland Health
Express Scripts
Cipla
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot